Antimony Toxicity

Available online: http://www.atsdr.cdc.gov/tfacts23.html.

Available online: http://www.health.gov.sk.ca/water-guidelines-water-quality.

Available online: http://www.inchem.org/documents/iarc/vol47/47-11.html.

McCallum, RI (1999). Antimony in Medical History, The Pentland Press.

Available online: http://www.atsdr.cdc.gov/toxprofiles/tp23.html.

Iyengar, 1987, Preparation of a mixed human diet material for the determination of nutrient elements, selected toxic elements and organic nutrients: A preliminary report, Sci. Total Environ, 61, 235, 10.1016/0048-9697(87)90371-8

Thomas, 1973, Retention patterns of antimony in mice following inhalation of particles formed at different temperatures, Proc. Exp. Biol. Med, 144, 544, 10.3181/00379727-144-37632

Felicetti, 1974, Retention of inhaled antimony-124 in the beagle dog as a function of temperature of aerosol formation, Health Phys, 26, 525, 10.1097/00004032-197406000-00006

Cooper, 1968, Pneumoconiosis among workers in an antimony industry, Am. J. Roentgen. Rad. Ther. Nuclear Med, 103, 495, 10.2214/ajr.103.3.495

Potkonjak, 1983, Antimoniosis: A particular form of pneumoconiosis. I. Etiology, clinical and x-ray findings, Int. Arch. Occup. Environ. Health, 51, 199, 10.1007/BF00377752

Karajovic, D Pneumokoniosen bei arbeitern einer antimonhutte. (Cited in Public Health Goal for Antimony in Drinking Water; Prepared by Pesticide and Environmental Toxicology Section Office of Environmental Health Hazard Assessment California Environmental Protection Agency December 1997).

Gross, 1955, Toxicologic study of calcium halophosphate phosphors and antimony trioxide. II. Pulmonary studies, AMA Arch. Ind. Health, 11, 479

Brieger, 1954, Industrial antimony poisoning, Ind. Med. Surg, 23, 521

Taylor, 1966, Acute intoxication from antimony trichloride, Br. J. Ind. Med, 23, 318

Renes, 1953, Antimony poisoning in industry, Arch. Ind. Hyg, 7, 99

Stevenson, 1965, Antimony spots, Trans. St. Johns Hosp. Dermatol. Soc, 51, 40

White, 1993, Dermatitis in workers exposed to antimony in a melting process, J. Occup. Med, 35, 392

Belyaeva, 1967, The effect of antimony on reproduction, Gig. Truda. Prof. Zabol, 11, 32

Paton, 1972, Chromosome damage in human cell cultures induced by metal salts, Mutat. Res, 16, 332, 10.1016/0027-5107(72)90166-2

Cavallo, 2002, Genotoxic risk and oxidative DNA damage in workers exposed to antimony trioxide, Environ. Mol. Mutagen, 40, 184, 10.1002/em.10102

Asakura, 2009, Genotoxicity studies of heavy metals: Lead, Bismuth, Indium, Silver and Antimony, J. Occup. Health, 51, 498, 10.1539/joh.L9080

Dunn, 1928, A curious case of antimony poisoning, Analyst, 531, 532

Richardson, 1990, Cot mattress biodeterioration and SIDS, Lancet, 335, 670, 10.1016/0140-6736(90)90463-F

Cullen, 2000, Concentrations of antimony in infants dying from SIDS and infants dying from other causes, Arch. Dis. Child, 82, 244, 10.1136/adc.82.3.244

Durgam, 2010, A health hazard evaluation of antimony exposure in fire fighters, J. Occup. Environ. Med, 52, 81, 10.1097/JOM.0b013e3181c7514a

Niosh Safety and Health Topic: Fire Fighter Fatality Investigation and Prevention Program. Available online: http://www.cdc.gov/niosh/fire/spotlight.html.

(1995). EPA 811-F-95-002j-T, Office of Water, US Environmental Protection Agency.

Available online: http://www.who.int/water_sanitation_health/dwq/chemicals/antimony.pdf.

Sneader, W (2005). Drug Discovery: A History, John Wiley & Sons.

Farid, 1968, Urinary schistosomiasis treated with sodium antimony tartrate a quantitative evaluation, Brit. Med. J, 3, 713, 10.1136/bmj.3.5620.713

Davis, 1968, Comparative trials of antimonial drugs on urinary schistosomiasis, Bull. World Health Organ, 38, 197

Cook, 1993, Leishmaniasis: some recent developments in chemotherapy, J. Antimicrob. Chemother, 31, 327, 10.1093/jac/31.3.327

(1941). Conquest of kala-azar. Science and Culture, VI, 528–534.

Herwaldt, 1992, Recommendations for treating leishmaniasis with sodium stibogluconate (Pentostam) and review of pertinent clinical studies, Am. J. Trop. Med. Hyg, 46, 296, 10.4269/ajtmh.1992.46.296

Navin, 1992, Placebo-controlled clinical trial of sodium stibogluconate (Pentostam) versus ketoconazole for treating cutaneous leishmaniasis in Guatemala, J. Infect. Dis, 165, 528, 10.1093/infdis/165.3.528

Chulay, 1985, Electrocardiographic changes during treatment of leishmaniasis with pentavalent antimony (sodium stibogluconate), Am. J. Trop. Med. Hyg, 34, 792, 10.4269/ajtmh.1985.34.702

Sundar, 1997, Response to interferon-g plus antimony in Indian visceral leishmaniasis, J. Infect. Dis, 176, 1117, 10.1086/516526

Singh, 1989, Kala-azar mortality in hospitalized cases in North Bihar, India, J. Assoc. Physicians India, 37, 514

Braunwald, E (1984). Heart Diseases, W. B. Saunders Co. [2nd ed].

Sundar, 1998, A cluster of cases of severe cardiotoxicity among Kala-Azar patients treated with a high-osmolarity lot of sodium antimony gluconate, Am. J. Trop. Med. Hyg, 59, 139, 10.4269/ajtmh.1998.59.139

Rijal, 2003, Sodium stibogluconate cardiotoxicity and safety of generics, Trans. R. Soc. Trop. Med. Hyg, 97, 597, 10.1016/S0035-9203(03)80043-3

Kuryshev, 2006, Antimony-based antileishmanial compounds prolong the cardiac action potential by an increase in cardiac calcium currents, Mol. Pharmacol, 69, 1216, 10.1124/mol.105.019281

Croft, 2006, Drug Resistance in Leishmaniasis, Clin. Microbiol. Rev, 19, 111, 10.1128/CMR.19.1.111-126.2006

Miller, 2002, Mechanism of action of arsenic trioxide, Cancer Res, 62, 3893

Delgado, 1999, High frequency of serious side effects from meglumine antimoniate given without an upper limit dose for the treatment of visceral leishmaniasis in human immunodeficiency virus type 1-infected patients, Am. J. Trop. Med. Hyg, 61, 766, 10.4269/ajtmh.1999.61.766

Franco, 1995, Antimony oxidation states in antileishmanial drugs, Am. J. Trop. Med. Hyg, 52, 435, 10.4269/ajtmh.1995.52.435

Murthy, 1992, Hyperamylasemia in patients with the acquired immunodeficiency syndrome, Am. J. Gastroenterol, 87, 332

Cappell, 1997, The pancreas in AIDS, Gastroenterol. Clin. North Am, 26, 337, 10.1016/S0889-8553(05)70298-3

Soto, 2004, Comparison of generic to branded pentavalent antimony for treatment of new world cutaneous leishmaniasis, Am. J. Trop. Med. Hyg, 71, 577, 10.4269/ajtmh.2004.71.577

Romero, 2003, High frequency of skin reactions in patients with leishmaniasis treated with meglumine antimoniate contaminated with heavy metals: a comparative approach using historical controls, Mem. Inst. Oswaldo. Cruz, 98, 145, 10.1590/S0074-02762003000100019

Olliaro, 2009, Anthropometrically derived dosing and drug costing calculations for treating visceral leishmaniasis in Bihar, India, Trop. Med. Int. Health, 14, 88, 10.1111/j.1365-3156.2008.02195.x

Seaman, 1993, Epidemic visceral leishmaniasis in Sudan: a randomized trial of aminosidine plus sodium stibogluconate versus sodium stibogluconate alone, J. Infect. Dis, 168, 715, 10.1093/infdis/168.3.715

Chunge, 1990, Treatment of visceral leishmaniasisin Kenya by aminosidine alone or combined with sodium stibogluconate, Trans. R. Soc. Trop. Med. Hyg, 84, 221, 10.1016/0035-9203(90)90263-E

Thakur, 1992, Treatment of visceral leishmaniasis (kala-azar) with aminosidine (=paromomycin)-antimonial combinations, a pilot study in Bihar, India, Trans. R. Soc. Trop. Med. Hyg, 86, 615, 10.1016/0035-9203(92)90150-B

Melaku, 2007, Treatment of kala-azar in southern Sudan using a 17-day regimen of sodium stibogluconate combined with paromomycin: a retrospective comparison with 30-day sodium stibogluconate monotherapy, Am. J. Trop. Med. Hyg, 77, 89, 10.4269/ajtmh.2007.77.89